top of page
© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

1 Agosti 2026, 07:45:23

Image-empty-state.png

Catheter-Associated Urinary Tract Infection (CAUTI)- Management

Catheter-associated urinary tract infection (CAUTI) is a urinary tract infection that occurs in a patient with an indwelling urinary catheter or within 48 hours of catheter removal. It is one of the most common healthcare-associated infections worldwide and accounts for a significant proportion of nosocomial infections. The risk of infection increases with the duration of catheterization, as urinary catheters facilitate bacterial entry into the urinary tract and promote biofilm formation.


CAUTI may present as lower urinary tract infection (cystitis), upper urinary tract infection (pyelonephritis), or severe systemic infection leading to urosepsis. Early recognition, appropriate antimicrobial therapy, and timely catheter management are essential to reduce morbidity and prevent complications.


The most common causative organisms include Escherichia coli, Klebsiella pneumoniae, Proteus species, Pseudomonas aeruginosa, Enterococcus species, and Staphylococcus aureus.


Epidemiology

CAUTI is the most common healthcare-associated urinary tract infection. The risk of bacteriuria increases by approximately 3–7% for each day an indwelling catheter remains in place. Long-term catheterized patients are particularly susceptible to recurrent infections, antimicrobial resistance, and complications.

Hospitalized patients, residents of long-term care facilities, critically ill patients, and individuals with neurogenic bladder are at greatest risk.


Risk factors


Catheter-related factors

  • Prolonged urinary catheterization

  • Breaks in aseptic catheter insertion technique

  • Improper catheter care

  • Repeated catheter manipulation

  • Catheter obstruction

  • Large catheter size

  • Inadequate drainage system maintenance


Patient-related factors

  • Advanced age

  • Female sex

  • Diabetes mellitus

  • Chronic kidney disease

  • Immunosuppression

  • Neurogenic bladder

  • Urinary tract obstruction

  • Critical illness

  • Prolonged hospitalization

  • Previous urinary tract infection


Pathophysiology

Urinary catheters bypass the body's natural defense mechanisms and provide a direct route for microorganisms to enter the urinary tract. Bacteria may ascend externally along the catheter surface or internally through the catheter lumen.


Microorganisms adhere to the catheter surface and form biofilms, which protect them from host immune responses and antimicrobial agents. This facilitates persistent colonization and infection. Infection may remain localized within the bladder or ascend to involve the kidneys, resulting in pyelonephritis. In severe cases, bacteria may enter the bloodstream and cause urosepsis.


Clinical presentation

CAUTI should be suspected in any catheterized patient who develops signs or symptoms consistent with urinary tract infection.


Symptoms

Symptoms may include:

  • Fever

  • Chills

  • Suprapubic pain

  • Lower abdominal discomfort

  • Flank pain

  • Dysuria after catheter removal

  • Urinary urgency following catheter removal

  • Malaise

  • Nausea

  • Vomiting

Symptoms may be absent in some patients, particularly elderly individuals and those with long-term catheters.


Clinical signs

  • Fever (≥38°C)

  • Suprapubic tenderness

  • Costovertebral angle tenderness

  • Flank tenderness

  • Cloudy urine

  • Foul-smelling urine

  • Catheter blockage

  • Tachycardia

  • Hypotension in severe cases

  • Altered mental status in elderly patients

  • Signs of sepsis in advanced infection


Diagnostic criteria

CAUTI is diagnosed when:

  • A patient has a urinary catheter in place or had one removed within the previous 48 hours; and

  • Clinical signs or symptoms of urinary tract infection are present; and

  • Laboratory evidence supports urinary tract infection.


Diagnosis is strengthened by:

  • Pyuria on urinalysis

  • Significant bacteriuria on urine culture

  • Positive urine culture with a recognized urinary pathogen

Asymptomatic bacteriuria alone should not be diagnosed as CAUTI unless specific clinical indications for treatment exist.


Investigations


Urinalysis

  • Leukocyte esterase

  • Nitrite test

  • Protein

  • Blood

  • Urinary pH


Urine microscopy

  • White blood cells

  • Red blood cells

  • Bacteria


Urine culture and antimicrobial susceptibility testing

Urine culture should be obtained before initiation of antimicrobial therapy whenever possible. Specimens should be collected aseptically from the catheter sampling port rather than the drainage bag.


Blood investigations

  • Full blood count

  • Serum creatinine

  • Blood urea nitrogen

  • Serum electrolytes

  • C-reactive protein

  • Blood cultures in patients with fever or suspected sepsis


Imaging studies

Imaging may be indicated when complications are suspected:

  • Ultrasound of kidneys and bladder

  • CT scan of the urinary tract

  • Assessment for urinary obstruction, stones, or abscess formation


Management

Management of catheter-associated urinary tract infection requires careful assessment because patients with indwelling urinary catheters, suprapubic catheters, and nephrostomy tubes commonly become colonized with potential bacterial pathogens. Routine antimicrobial treatment of asymptomatic bacteriuria is not indicated. Antimicrobial therapy should only be initiated when there is clinical and laboratory evidence of infection.


The objectives of management are:

  • Confirm true infection before initiating antibiotics.

  • Remove or replace unnecessary urinary devices.

  • Treat infection based on clinical severity and antimicrobial susceptibility results.

  • Prevent recurrence through appropriate catheter care.


Non-pharmacological treatment

  • Assess the continued need for catheterization.

  • Remove indwelling catheters when no longer clinically required.

  • Replace catheter or nephrostomy tube when indicated, particularly if obstruction or prolonged use is present.

  • Maintain aseptic catheter care.

  • Ensure adequate hydration.

  • Monitor for signs of progression to pyelonephritis or urosepsis.


Pharmacological treatment

Antimicrobial therapy should only be given when CAUTI is supported by clinical and laboratory evidence.


Adults

  • Ciprofloxacin 500 mg orally every 12 hours for 7 days.

Antimicrobial therapy should subsequently be modified according to urine culture and antimicrobial sensitivity results.


Management according to underlying cause


Long-term catheterization

  • Review the indication for catheterization.

  • Consider intermittent catheterization where feasible.

  • Replace long-term catheters at appropriate intervals.


Urinary tract obstruction

  • Relieve obstruction urgently.

  • Treat underlying pathology.


Neurogenic bladder

  • Optimize bladder emptying techniques.

  • Consider specialist urological evaluation.


Urinary stones

  • Treat infection first.

  • Manage calculi after stabilization.


Referral

Refer the patient if:

  • Pyelonephritis develops

  • Urosepsis is suspected

  • There is persistent infection despite treatment

  • Recurrent CAUTIs occur

  • Urinary tract obstruction is present

  • Renal impairment develops

  • Urinary tract abnormalities require specialist management

  • Multidrug-resistant organisms are identified

  • Surgical intervention is required


Complications

  • Recurrent urinary tract infection

  • Acute pyelonephritis

  • Renal abscess

  • Perinephric abscess

  • Acute kidney injury

  • Catheter blockage

  • Urosepsis

  • Septic shock

  • Bacteraemia

  • Increased antimicrobial resistance

  • Prolonged hospitalization

  • Death in severe cases


Prognosis

The prognosis is generally good when infection is recognized early, the catheter is appropriately managed, and effective antimicrobial therapy is administered. Delayed treatment, persistent catheterization, multidrug-resistant organisms, and severe comorbidities increase the risk of complications and mortality.


Prevention

  • Avoid unnecessary urinary catheterization.

  • Use urinary catheters only when clinically indicated.

  • Employ aseptic technique during catheter insertion.

  • Maintain a closed drainage system.

  • Ensure proper catheter care and hygiene.

  • Remove catheters as soon as they are no longer required.

  • Avoid unnecessary catheter manipulation.

  • Educate healthcare workers on infection prevention practices.

  • Monitor catheterized patients regularly for signs of infection.

  • Implement hospital CAUTI prevention protocols.

Imeandikwa:

25 Mei 2026, 17:03:29

Rejea za mada hii:

  1. Ministry of Health, Community Development, Gender, Elderly and Children. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 6th ed. Dodoma: Ministry of Health; 2021.

  2. European Association of Urology. EAU Guidelines on Urological Infections. Arnhem: EAU Guidelines Office; 2025.

  3. Centers for Disease Control and Prevention. Guideline for Prevention of Catheter-Associated Urinary Tract Infections. Atlanta: CDC; 2024.

  4. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention and treatment of catheter-associated urinary tract infection in adults. Clin Infect Dis. 2010;50(5):625-663.

  5. World Health Organization. Global report on infection prevention and control. Geneva: World Health Organization; 2022.

  6. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.

bottom of page